Connection

Kathrin Jansen to Antigens, Bacterial

Back to Details
This is a "connection" page, showing publications Kathrin Jansen has written about Antigens, Bacterial.
Kathrin Jansen
Connection Strength
1.243
Antigens, Bacterial
  1. Reevaluation of Positivity Cutoff Values for the Pneumococcal Urinary Antigen Detection Assay. Clin Vaccine Immunol. 2017 11; 24(11).
    View in: PubMed
    Score: 0.555
  2. From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine. Expert Rev Vaccines. 2018 06; 17(6):461-477.
    View in: PubMed
    Score: 0.145
  3. A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults. N Engl J Med. 2017 12 14; 377(24):2349-2362.
    View in: PubMed
    Score: 0.140
  4. Bactericidal activity of sera from adolescents vaccinated with bivalent rLP2086 against meningococcal serogroup B outbreak strains from France. Vaccine. 2017 03 13; 35(11):1530-1537.
    View in: PubMed
    Score: 0.132
  5. SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies. Vaccine. 2017 02 22; 35(8):1132-1139.
    View in: PubMed
    Score: 0.131
  6. A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents. Pediatr Infect Dis J. 2013 Apr; 32(4):364-71.
    View in: PubMed
    Score: 0.101
  7. S. aureus colonization in healthy Australian adults receiving an investigational S. aureus 3-antigen vaccine. J Infect. 2019 12; 79(6):582-592.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.